LAT and glioblastoma: One study showed that the proportion of glioblastoma and metastatic tumour cells expressing LAT1 was 3 times higher than the proportion expressing proliferating cell nuclear antigen (PCNA), a marker of cell proliferation, suggesting that quiescent cell populations, such as those that occupy hypoxic tumour regions, do in fact express LAT1 [80].